With double the number of annual exits since 2014, and total deal volume increasing by more than 500% MedTech attracts more than 25% of total technology capital investment in Israel. This environment has served as a fertile proving ground for building experience in a market with complex solutions.
Over the past 5 years nearly 80 Israeli companies in the Life Sciences sector have delivered high-ratio returns on exits totaling more than $5 billion. Among the largest deal makers were MedTech companies including Given Imaging, Lumenis, Syneron, and Mazor with exits between $400M and $1.6B. In fact, every dollar invested in these past years in Life Sciences companies, returned $13 on average.
Leave us a brief message explaining how we can help you and an InvestMed representative will respond shortly. In your message, please indicate if your interest is in investing, in becoming an InvestMed portfolio company, partnering with InvestMed or in another area.